Dr. Sondak has been a paid consultant and provided expert testimony for Merck/Schering-Plough. The other authors have no relevant disclosures.
Current and planned multicenter trials for patients with primary or metastatic melanoma†
Article first published online: 19 AUG 2011
Copyright © 2011 Wiley-Liss, Inc.
Journal of Surgical Oncology
Special Issue: Seminars in Surgical Oncology: Melanoma
Volume 104, Issue 4, pages 430–437, 15 September 2011
How to Cite
Sondak, V. K., Han, D., Deneve, J. and Kudchadkar, R. (2011), Current and planned multicenter trials for patients with primary or metastatic melanoma. J. Surg. Oncol., 104: 430–437. doi: 10.1002/jso.21867
- Issue published online: 17 AUG 2011
- Article first published online: 19 AUG 2011
- Manuscript Accepted: 16 DEC 2010
- Manuscript Received: 2 DEC 2010
- clinical trials;
- sentinel node biopsy
Multicenter clinical trials have established new standards of care in the surgical and medical management of malignant melanoma. They have led to the testing of new therapies and improved outcomes for patients with loco-regional and distant disease. Many pressing questions remain, however, and additional multicenter trials are currently underway to address them. The purpose of this review is to summarize relevant ongoing and planned multicenter trials that have and continue to define current melanoma management. J. Surg. Oncol. 2011; 104:430–437. © 2011 Wiley-Liss, Inc.